AAIC 2025 Conference Symposium Agenda
Inhibition of β-Amyloid Oligomer Neurotoxicity with Oral Valiltramiprosate
Dr. Cohen [00:00] | Chair’s Welcome & Program Objectives |
Dr. Gandy [07:42] | Pathogenic Role of Beta Amyloid Oligomers in AD |
Dr. Ono [20:20] | Insights into Mechanism of Action of Valiltramiprosate |
Dr. Geerts [34:35] | QSP Analysis of Inhibition of Amyloid Oligomer Formation by Valiltramiprosate |
Dr. Hey [45:45] | Disease Modifying Effects of Valiltramiprosate in Early Symptomatic AD |
Dr. Cohen [1:03:20] | Questions & Answers |